Clinical Trial Update: Domperidone in Secondary Progressive Multiple Sclerosis (SPMS) [Phase 2]

View source ↗

Summary

Phase 2 trial update on domperidone for secondary progressive multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Secondary Progressive

Drugs mentioned

• Domperidone (domperidone)

Snippet

Sponsor: University of Calgary | Conditions: Multiple Sclerosis, Secondary Progressive | Phase 2 | Status: COMPLETED